NCT07259213 2026-03-12
RAD402
Radiopharm Theranostics, Ltd
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT06636123 2026-01-27
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
Virginia Commonwealth University
Phase 1 Recruiting
NCT06585007 2024-09-05
MEDCARE
Universitaire Ziekenhuizen KU Leuven
Phase 3 Recruiting
NCT06227156 2024-05-23
Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer
RemeGen Co., Ltd.
Phase 2 Recruiting
NCT06321679 2024-03-20
RESPECT
European Institute of Oncology
Recruiting